| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0014 | 1 |